Bim is a suppressor of Myc-induced mouse B cell leukemia.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-04-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0401471101PMID 15079075PMCID PMC395940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

  2004cited by this paper
• Bad-deficient mice develop diffuse large B cell lymphoma

  2003cited by this paper
• The Bcl-2 family: roles in cell survival and oncogenesis

  2003cited by this paper
• Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival.

  2003cited by this paper
• Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

  2003cited by this paper
• Loss of the Pro-Apoptotic BH3-only Bcl-2 Family Member Bim Inhibits BCR Stimulation–induced Apoptosis and Deletion of Autoreactive B Cells

  2003cited by this paper
• Proapoptotic BID is required for myeloid homeostasis and tumor suppression.

  2003cited by this paper
• PUMA mediates the apoptotic response to p53 in colorectal cancer cells

  2003cited by this paper
• p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa

  2003cited by this paper
• Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs.

  2002cited by this paper
• BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes

  2002cited by this paper
• The Bcl2 family: regulators of the cellular life-or-death switch

  2002cited by this paper
• A view to a kill: ligands for Bcl-2 family proteins.

  2002cited by this paper
• The INK4a/ARF network in tumour suppression

  2001cited by this paper
• PUMA, a novel proapoptotic gene, is induced by p53.

  2001cited by this paper
• Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim.

  2001cited by this paper
• Bmf: A Proapoptotic BH3-Only Protein Regulated by Interaction with the Myosin V Actin Motor Complex, Activated by Anoikis

  2001cited by this paper
• Gene structure, alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim

  2001cited by this paper
• Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis

  2001cited by this paper
• MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes.

  2001cited by this paper
• The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells.

  2000cited by this paper
• Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

  2000cited by this paper
• The Hallmarks of Cancer Review

  2000cited by this paper
• Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

  1999cited by this paper
• Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.

  1999cited by this paper
• Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

  1999cited by this paper
• Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

  1999cited by this paper
• INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

  1999cited by this paper
• Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation.

  1999cited by this paper
• Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

  1998cited by this paper
• Bim: a novel member of the Bcl‐2 family that promotes apoptosis

  1998cited by this paper
• Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis

  1997cited by this paper
• The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.

  1996cited by this paper
• Progenitor tumours from Emu‐bcl‐2‐myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival.

  1996cited by this paper
• Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.

  1995cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of E mu-myc transgenic mice.

  1994cited by this paper
• Census 2000 planning.

  1993cited by this paper
• E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.

  1993cited by this paper
• Induction of apoptosis in fibroblasts by c-myc protein.

  1992cited by this paper
• Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

  1991cited by this paper
• Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

  1991cited by this paper
• Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2

  1990cited by this paper
• The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

  1988cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper
• The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.

  1986cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper

• Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.

  2026cites this paper
• Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma

  2025cites this paper
• Apoptosis in Cancer Biology and Therapy.

  2025cites this paper
• MNT: a new target for AML

  2025cites this paper
• Targeting Cancer Cell Fate: Apoptosis, Autophagy, and Gold Nanoparticles in Treatment Strategies

  2025cites this paper
• DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition

  2025cites this paper
• MYC shapes ER-mitochondria calcium transfer by directly targeting ITPR1: implications for MYC-induced safeguard mechanisms and cancer

  2024cites this paper
• Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy.

  2024cites this paper
• Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks.

  2024cites this paper
• Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening

  2024cites this paper
• Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice

  2024cites this paper
• The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies

  2024cites this paper
• Antioxidant Defenses, Oxidative Stress Responses, and Apoptosis Modulation in Spontaneous Abortion: An Immunohistochemistry Analysis of First-Trimester Chorionic Villi

  2024cites this paper
• Bio-mimetic strategies to re-activate apoptotic cell death for cancer treatments

  2024cites this paper
• MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis

  2023cites this paper
• Role of intrinsic apoptosis in environmental exposure health outcomes.

  2023cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma

  2022cites this paper
• Combination therapies to inhibit LCK tyrosine kinase and mTOR signaling in T-cell Acute Lymphoblastic Leukemia.

  2022cites this paper
• Nasal and nasopharyngeal Burkitt’s lymphoma in pediatric age group – A review

  2022cites this paper
• Burkitt lymphoma

  2022cites this paper
• 50 years on and still very much alive: ‘Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics’

  2022cites this paper
• Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase

  2022cites this paper
• Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives

  2022cites this paper
• BCL-2 protein family: attractive targets for cancer therapy

  2022cites this paper
• A systems genetics approach delineates the role of Bcl2 in leukemia pathogenesis.

  2022cites this paper
• HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-myc axis.

  2022cites this paper
• Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes.

  2021cites this paper
• Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.

  2021cites this paper
• Somatic Mutations and Autoimmunity

  2021cites this paper
• BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax/Bak-independent cell death in B-cell cancers through mitochondrial Ca2+-dependent mPTP opening.

  2021cites this paper
• The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs

  2021cites this paper
• IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3

  2021cites this paper
• Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.

  2021cites this paper
• Tilting MYC toward cancer cell death.

  2021cites this paper
• Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer

  2021influential citation
• Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells

  2021cites this paper
• Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis

  2021cites this paper
• Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk

  2021cites this paper
• MYC’s Fine Line Between B Cell Development and Malignancy

  2020cites this paper
• Development and Survival of MYC-driven Lymphomas Requires MYC-Antagonist MNT to Curb MYC-induced Apoptosis.

  2020cites this paper
• Emerging connectivity of programmed cell death pathways and its physiological implications

  2020cites this paper
• SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells

  2020cites this paper
• BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

  2020cites this paper
• Lymphome de Burkitt

  2020cites this paper
• Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds

  2020cites this paper
• 5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis

  2020cites this paper
• The Role of Caspase-2 in Regulating Cell Fate

  2020cites this paper
• DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition

  2020cites this paper
• BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression.

  2020cites this paper
• Cell Death Pathways in Lymphoid Malignancies

  2020cites this paper
• EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

  2019cites this paper
• Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia

  2019cites this paper
• MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities

  2019cites this paper
• Pro-apoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.

  2019cites this paper
• Postmortem vs. neoplastic gene expression: Clues to cancer development and therapy.

  2019cites this paper
• Activation of the Extrinsic and Intrinsic Apoptotic Pathways in Cerebellum of Kindled Rats

  2019cites this paper
• Unmasking the Mysteries of MYC

  2019cites this paper
• IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis

  2019cites this paper
• Targeting the Bcl-2 Family in B Cell Lymphoma

  2019cites this paper
• The Functional Role of Bcl-2 Family of Proteins in the Immune System and Cancer

  2019cites this paper
• Harnessing The Pro-Apoptotic Function Of Myc To Improve Therapeutic Responses In Chemoresistant B-Cell Lymphoma

  2019cites this paper
• Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

  2019cites this paper
• B Cell Lymphomagenesis

  2019cites this paper
• Deficiency in the DNA glycosylases UNG1 and OGG1 does not potentiate c-Myc-induced B-cell lymphomagenesis.

  2018cites this paper
• Differential effects of Vav‐promoter‐driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis

  2018cites this paper
• Proapoptotic BIM Impacts B Lymphoid Homeostasis by Limiting the Survival of Mature B Cells in a Cell-Autonomous Manner

  2018cites this paper
• Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells

  2018cites this paper
• Venetoclax: A new wave in hematooncology.

  2018cites this paper
• Sensitivity and Resistance to BH3 Mimetics in Cancer Therapy

  2018cites this paper
• Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma

  2018influential citation
• BIM ( BCL-2 INTERACTING MEDIATOR PROTEIN OR BCL-2-LIKE PROTEIN 11 ) AND CANCER

  2018cites this paper
• Mcl-1 and Bcl-xL sequestration of Bak confers differential resistance to BH3-only proteins

  2018cites this paper
• An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model

  2018cites this paper
• Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma.

  2018cites this paper
• Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen‐independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis

  2018cites this paper
• Therapeutic vulnerability of multiple myeloma to MIR17PTi, a 1 first-in-class inhibitor of pri-mir-17-92 2

  2018cites this paper
• Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92.

  2018cites this paper
• Targeting BCL-2 regulated apoptosis in cancer

  2018cites this paper
• The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim

  2018cites this paper
• The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency

  2018cites this paper
• Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation

  2017cites this paper
• Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.

  2017cites this paper
• EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice.

  2017cites this paper
• BCL-W has a fundamental role in B cell survival and lymphomagenesis

  2017cites this paper
• Mnt modulates Myc-driven lymphomagenesis

  2017cites this paper
• The BCL-2 arbiters of apoptosis and their growing role as cancer targets

  2017cites this paper
• Dynein light chain 1 induces assembly of large Bim complexes on mitochondria that stabilize Mcl-1 and regulate apoptosis

  2017cites this paper
• Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

  2017cites this paper
• Expression pattern of BIM, BCL-6, and c-MYC in adult B-cell acute lymphoblastic leukemia

  2017cites this paper
• Expression: Relationship to Resistance to Leads to Down-Regulation of Bim EBV Infection of Human B Lymphocytes

  2017cites this paper
• Analysis of glucose homeostasis and beta cell mass in a mouse model of type 2 diabetes deficient in the pro-apoptotic protein BIM

  2017cites this paper
• Les lymphomes B diffus à grandes cellules de type activé : rôle de NF-κB et c-Myc.

  2017cites this paper
• Bim may be a poor prognostic biomarker in breast cancer patients especially in those with luminal A tumors

  2017cites this paper
• Loss of BIM increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice

  2017cites this paper
• Increase Signaling of Wnt/β-Catenin Pathway and Presence of Apoptosis in Cerebellum of Kindled Rats.

  2017cites this paper
• The transcriptional represser Mnt is a functional antagonist of the proto-oncoprotein Myc

  2017cites this paper
• BH3-Only Proteins in Health and Disease.

  2017cites this paper
• Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer.

  2017cites this paper
• miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal

  2017cites this paper